Mesoblast (MESO) News Today $10.97 +0.12 (+1.11%) Closing price 04:00 PM EasternExtended Trading$10.96 -0.01 (-0.09%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MESO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Mesoblast (NASDAQ:MESO) Stock Price Crosses Below 50-Day Moving Average - Time to Sell?Mesoblast (NASDAQ:MESO) Stock Passes Below 50-Day Moving Average - Here's WhyMay 26 at 5:35 AM | marketbeat.comMesoblast (NASDAQ:MESO) Shares Gap Down - Here's What HappenedMesoblast (NASDAQ:MESO) Shares Gap Down - What's Next?May 24 at 11:44 AM | marketbeat.comCubist Systematic Strategies LLC Has $697,000 Position in Mesoblast Limited (NASDAQ:MESO)Cubist Systematic Strategies LLC increased its position in Mesoblast Limited (NASDAQ:MESO - Free Report) by 241.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,191 shares of the company's stock after buying an additMay 18, 2025 | marketbeat.comHotCopper Highlights Week 20: Mesoblast FDA miss; Larvotto posts tungsten, Melbana & MoreMay 16, 2025 | msn.comMesoblast Limited: FDA Provides Seven Years of Orphan-Drug Exclusive Approval for RyoncilMay 15, 2025 | finanznachrichten.deIs Mesoblast Limited (MESO) the Best Australian Stock to Buy According to Analysts?May 15, 2025 | msn.comThursday’s HotCopper trends: Mesoblast's FDA tick, Anson's green light | May 15, 2025May 15, 2025 | msn.comFDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®May 14, 2025 | globenewswire.comMesoblast Limited's (ASX:MSB) market cap dropped AU$96m last week; Individual investors bore the bruntMay 7, 2025 | finance.yahoo.comMesoblast Limited's (ASX:MSB) market cap dropped AU$96m last week; Individual investors bore the bruntMay 7, 2025 | finance.yahoo.comBullish On Mesoblast: Shifting To Commercial Stage With Ryoncil Approval And Revascor TrialsMay 5, 2025 | seekingalpha.comAppendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025April 29, 2025 | globenewswire.comMesoblast Appoints Corporate Finance Leader Lyn Cobley To BoardApril 28, 2025 | globenewswire.comMesoblast extends payer coverage for Ryoncil to over 100M U.S. livesApril 17, 2025 | markets.businessinsider.comMesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US LivesApril 16, 2025 | globenewswire.comMesoblast (NASDAQ:MESO) Shares Gap Down - Here's WhyMesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell?April 13, 2025 | marketbeat.comMesoblast (NASDAQ:MESO) Shares Gap Up - Still a Buy?Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's WhyApril 10, 2025 | marketbeat.comTop broker says Mesoblast shares can rocket 100%April 7, 2025 | msn.comCantor Fitzgerald Upgrades Mesoblast (NASDAQ:MESO) to "Strong-Buy"Cantor Fitzgerald raised shares of Mesoblast to a "strong-buy" rating in a report on Monday.April 5, 2025 | marketbeat.comHotCopper Highlights for Week 14 – Mesoblast, Cettire, Neurizon & more!April 4, 2025 | msn.comMesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin' and Not Subject to U.S. TariffsApril 3, 2025 | globenewswire.comFY2025 EPS Estimates for Mesoblast Cut by Cantor FitzgeraldMesoblast Limited (NASDAQ:MESO - Free Report) - Equities researchers at Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for shares of Mesoblast in a report issued on Monday, March 31st. Cantor Fitzgerald analyst K. Kluska now expects that the company will earn ($0.71) per shApril 3, 2025 | marketbeat.comMesoblast (ASX:MSB) Announces Ryoncil Availability But Sees 15% Price Drop Over Past WeekApril 2, 2025 | finance.yahoo.comMesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart FailureApril 2, 2025 | globenewswire.comMesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's WhyApril 2, 2025 | marketbeat.comMesoblast (NASDAQ:MESO) Trading 2.9% Higher - Here's What HappenedMesoblast (NASDAQ:MESO) Shares Up 2.9% - Here's What HappenedApril 1, 2025 | marketbeat.comOaktree Fund Advisors LLC Buys Shares of 47,909 Mesoblast Limited (NASDAQ:MESO)Oaktree Fund Advisors LLC bought a new position in Mesoblast Limited (NASDAQ:MESO - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 47,909 shares of the company's stMarch 31, 2025 | marketbeat.comMesoblast announces it entered into NDRA with CMS DHHS for RyoncilMarch 31, 2025 | markets.businessinsider.comOaktree Capital Management LP Takes $3.56 Million Position in Mesoblast Limited (NASDAQ:MESO)Oaktree Capital Management LP bought a new position in shares of Mesoblast Limited (NASDAQ:MESO - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 179,593 shares of the company's stock, valued at approximMarch 31, 2025 | marketbeat.comMesoblast kicks off treatment for first 3 kids with graft-host disease. So why are shares down?March 31, 2025 | msn.comFirst Three Children to Commence Treatment With Ryoncil®March 30, 2025 | globenewswire.comMesoblast Becomes Oversold (MESO)March 30, 2025 | nasdaq.comMesoblast (NASDAQ:MESO) Stock Price Down 7% - What's Next?Mesoblast (NASDAQ:MESO) Trading Down 7% - Time to Sell?March 29, 2025 | marketbeat.com2 ASX 200 biotech stocks announcing big news todayMarch 28, 2025 | msn.comRyoncil® is Now Available for Purchase in the United StatesMarch 26, 2025 | globenewswire.comMesoblast (NASDAQ:MESO) Shares Gap Up - What's Next?Mesoblast (NASDAQ:MESO) Shares Gap Up - Still a Buy?March 21, 2025 | marketbeat.comA chronographic analysis of MSC's rollercoasting journeyMarch 18, 2025 | finance.yahoo.comRyoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United StatesMarch 13, 2025 | globenewswire.comMesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - What's Next?March 12, 2025 | marketbeat.comMesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town HallMarch 12, 2025 | globenewswire.comMesoblast Limited (MESO): Among the Best Australian Stocks to Buy According to BillionairesMarch 10, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Down 5.7% - What's Next?Mesoblast (NASDAQ:MESO) Trading Down 5.7% - Here's WhyMarch 7, 2025 | marketbeat.comMesoblast Added to S&P/ASX 200 INDEXMarch 7, 2025 | markets.businessinsider.comCantor Fitzgerald Predicts Mesoblast FY2025 EarningsMesoblast Limited (NASDAQ:MESO - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Mesoblast in a research report issued to clients and investors on Tuesday, March 4th. Cantor Fitzgerald analyst K. Kluska anticipates that the company will post earnings per share oMarch 7, 2025 | marketbeat.comMesoblast (NASDAQ:MESO) Rating Increased to Strong-Buy at Cantor FitzgeraldCantor Fitzgerald upgraded Mesoblast to a "strong-buy" rating in a research report on Tuesday.March 6, 2025 | marketbeat.comAPRA targets boards; Cyclone Alfred intensifies; Trump’s chain reactionMarch 6, 2025 | afr.comWhy Appen, Mesoblast, Rio Tinto, and Woodside shares are falling todayMarch 6, 2025 | msn.comListen: HotCopper Podcast 004 – Trump gets his trade war, Mesoblast losing steamMarch 5, 2025 | msn.comJefferies Keeps Their Hold Rating on Mesoblast Limited (MEOBF)March 3, 2025 | markets.businessinsider.comMesoblast Limited (NASDAQ:MESO) Q2 2025 Earnings Call TranscriptMarch 3, 2025 | msn.com Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address MESO Media Mentions By Week MESO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MESO News Sentiment▼0.530.78▲Average Medical News Sentiment MESO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MESO Articles This Week▼23▲MESO Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGTX News Today LEGN News Today NUVL News Today AXSM News Today LNTH News Today ADMA News Today PCVX News Today RYTM News Today MRUS News Today SRPT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MESO) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MESO Stock Free MESO Stock Alerts